In this respect, Chuang et al.69 demonstrated that COX-2 inhibition is not sufficient to explain the cytotoxic effect of celecoxib in pancreatic carcinoma and glioblastoma cell lines expressing variable levels of COX-2. This evidence concerns the gene PTGS2 and glioblastoma.